Drug Information

Drug General Information
Drug ID
D04AMC
Former ID
DNC006379
Drug Name
N-arachidonoyl-N-(2-hydroxyethyl)hydroxylamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528112]
Structure
Download
2D MOL

3D MOL
Formula
C22H37NO3
Canonical SMILES
CCCCCC=CCC=CCC=CCC=CCCCC(=O)N(CCO)O
InChI
1S/C22H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23(26)20-21-24/h6-7,9-10,12-13,15-16,24,26H,2-5,8,11,14,17-21H2,1H3/b7-6-,10-9-,13-12-,16-15-
InChIKey
GSKSTUBDYCGHNA-DOFZRALJSA-N
PubChem Compound ID
11559610
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [528112]
Cannabinoid receptor 2 Target Info Inhibitor [528112]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signalinghsa04080:Neuroactive ligand-receptor interaction
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like
References
Ref 528112J Med Chem. 2006 Apr 6;49(7):2333-8.Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity.
Ref 528112J Med Chem. 2006 Apr 6;49(7):2333-8.Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.